Evidence map›Paper›PMID 39416717›Full record

ArticleACS applied polymer materials2024

Cross-Linked Polyolefins: Opportunities for Fostering Circularity Throughout the Materials Lifecycle.

Alison J Shapiro, Paul J Brigandi, Maria Moubarak, Saurav S Sengupta, Thomas H Epps

Abstract read
In one paragraph

Article in ACS applied polymer materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alison J ShapiroDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware 19716, United States.ORCID https://orcid.org/0000-0002-4553-7421
Paul J BrigandiThe Dow Chemical Company, Collegeville, Pennsylvania 19426, United States.
Maria MoubarakThe Dow Chemical Company, Rheingaustrasse 34, 65201 Wiesbaden, Germany.
Saurav S SenguptaThe Dow Chemical Company, Collegeville, Pennsylvania 19426, United States.
Thomas H EppsDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware 19716, United States.ORCID https://orcid.org/0000-0002-2513-0966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross-linked polyolefins (XLPOs) constitute a significant portion of the plastics commercial market, with a market size of a similar order of magnitude to those of polystyrene and polyethylene terephthalate. However, few aspects of XLPO materials circularity have been examined relative to thermoplastic polyolefins. The cross-linking of polyolefins imparts superior performance properties, such as impact strength, chemical and electrical resistance, and thermal stability vs thermoplastic analogues, but it also makes the reprocessing of XLPOs to valuable products more challenging, as XLPOs cannot be molten. Thus, most XLPOs are incinerated or landfilled at the end of the first lifecycle, even though XLPO products are commonly collected as a relatively clean waste stream-providing a unique opportunity for valorization. In this review, we discuss approaches to improve XLPO circularity throughout the entire materials lifecycle by examining biobased feedstocks as alternative olefinic monomer sources and by assessing both traditional mechanical and advanced XLPO recycling methods based on industrial feasibility and potential product value. We also consider how advancing materials longevity can reduce environmental impacts and lifecycle costs and how recyclable-by-design strategies can enable better end-of-life opportunities for future generations of XLPO materials. Throughout this review, we highlight XLPO circularity routes that have the potential to balance the performance, circularity, and scalability necessary to impart economic and environmental viability at an industrial scale.

Identifiers

PMID39416717
PMCPMC11474822

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.